Consequently, CHI3L1 is described as a tissue remodelling factor and marker of neuroinflammation and macrophage as well as glial activation [23,37] and is discussed to be a suitable biomarker for MS disease activity and prognosis in the CSF [22,23,39,40]. The gene discussed is CHI3L1; the disease is myeloid sarcoma.